Plasma MERTK is causally associated with infection mortality

Michael Drozd1, Fergus Hamilton2, Chew W Cheng1

  • 1Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.

The Journal of Infection
|September 6, 2024
PubMed
Abstract

Insights

Plasma MERTK protein is causally linked to increased infection mortality risk. This finding suggests MERTK as a potential therapeutic target for infectious diseases, offering new avenues for treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Epidemiology

Background:

  • Infectious diseases remain a significant global cause of mortality despite existing interventions.
  • Identifying reliable biomarkers for infection mortality is crucial for public health strategies.

Purpose of the Study:

  • To identify plasma proteins associated with infection mortality.
  • To determine if these associations are causally driven using Mendelian randomization (MR).

Main Methods:

  • Utilized UK Biobank plasma proteomic data (n=52,520) to associate 2923 proteins with infection mortality.
  • Focused on proteins with >1.5-fold increased risk of infection mortality in a survivor-excluded analysis.
  • Employed Mendelian randomization (MR) with genome-wide association study (GWAS) data (n=363,953) to assess causality.

Main Results:

  • 1142 plasma proteins were associated with infection mortality risk (FDR <0.05).
  • 259 proteins showed a >1.5-fold increased risk for infection versus non-infection mortality.
  • Increasing MERTK protein concentration was causally associated with increased infection mortality risk (OR 1.46, p=0.002).

Conclusions:

  • Plasma MERTK protein is causally linked to infection mortality.
  • MERTK represents a potential novel therapeutic target for managing infectious diseases.